ctDNA Dynamics to Track Resistance in Metastatic Breast Cancer Treated With Anti-HER2 Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Oncotarget
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
ctDNA Dynamics: A Novel Indicator to Track Resistance in Metastatic Breast Cancer Treated With Anti-HER2 Therapy
Oncotarget 2016 Sep 01;[EPub Ahead of Print], F Ma, W Zhu, Y Guan, L Yang, X Xia, S Chen, Q Li, X Guan, Z Yi, H Qian, X Yi, B XuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.